San
Francisco, 14 November 2018 , The
global cell counting market is expected to reach
USD 10,679.7 million by 2025, according to a new report by Grand View
Research, Inc. Government initiatives working to promote development of cell
therapeutics, wherein cell counting plays an imperative role, is expanding
growth prospects for the market. As a result of extensive R&D activities,
the number of diseases treated with the help of stem cells increased to 82 in
2016 from 27 in 2005. Also, California Institute for Regenerative Medicine’s
funding of USD 271 million for stem cell therapy created 12 R&D facilities
in California, and these facilities brought approximately USD 543 million
funding. In addition, it is also funded by National Institutes of Health (NIH),
which approximately invested USD 1,429 million in 2015.
Increase in the number of collaborations of
research institutes with various public and private entities to promote R&D
has provided significant boost to the market. Growing number of proposed
guidelines and recommendations for public and private laboratories to ensure
high-quality standards and facilitate generation of accurate results are likely
to improve adoption of instruments over the coming years. For instance, in May
2016, the International Society for Stem Cell Research updated guidelines for
the development of cell-based therapy and research. The proposed guidelines
focus on all stages of R&D and improve quality of preclinical studies.
Full Research Report On Cell Counting Market Analysis:
Further
Key Findings From the Report Suggest:
·
Spectrophotometers accounted forthe largest
market share in 2016. This can be attributed to high penetration in various
applications such as toxicology studies, bioprocessing, and others
·
Automated counters were anticipated to grow
at an exponential rate during the forecast period. Benefits such as short
testing time, reduced error occurrence, and interoperator variability are
expected to further increase demand for automated counters
·
In the end-use segment, research and
academic institutes accounted for the largest market share in 2016, owing to
growing number of government initiatives focused toward promoting R&D in
various toxicology studies
·
Research and academic institutes are also
expected to witness exponential growth opportunities, owing to the growing
adoption of instruments for optimum drug concentration in therapeutics
·
North America held the largest share of the
market, owing to increase in number of supportive initiatives to fund R&D,
which is anticipated to result in higher adoption of automated instruments
·
Asia Pacific is anticipated to grow with a
lucrative CAGR during the forecast period. This lucrative growth rate is a
consequence of improvements in testing facilities
·
Level of competition is high as key players
are adopting strategies such as new product development and strategic
collaborations & agreements to gain competitive advantage
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global cell
counting market on the basis of product, end use, and region:
Cell Counting Product Outlook (Revenue, USD
Million, 2014 - 2025)
·
Instruments
o
Spectrophotometers
o
Flow Cytometers
o
Hematology Analyzers
o
Cell Counters
·
Consumables & Accessories
o
Reagents
o
Microplates
o
Others
Cell Counting End-use Outlook (Revenue, USD
Million, 2014 - 2025)
·
Hospitals & Diagnostic Laboratories
·
Research & Academic Institutes
·
Pharmaceutical & Biotechnology
Companies
·
Others
Cell Counting Regional Outlook (Revenue,
USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
o
France
o
Italy
o
Spain
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
o
Saudi Arabia
Access Full
Press Release of this Report:
www.grandviewresearch.com/press-release/global-cell-counting-market
www.grandviewresearch.com/press-release/global-cell-counting-market
About Grand View Research
Grand View Research, Inc.
is a U.S. based market research and consulting company, registered in the State
of California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more
information: www.grandviewresearch.com/
